Linked Life Data

16288016

Source:http://linkedlifedata.com/resource/pubmed/id/16288016

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16288016rdf:typepubmed:Citationlld:pubmed
pubmed-article:16288016lifeskim:mentionsumls-concept:C0684249lld:lifeskim
pubmed-article:16288016lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:16288016lifeskim:mentionsumls-concept:C0079419lld:lifeskim
pubmed-article:16288016lifeskim:mentionsumls-concept:C0596988lld:lifeskim
pubmed-article:16288016lifeskim:mentionsumls-concept:C0002085lld:lifeskim
pubmed-article:16288016lifeskim:mentionsumls-concept:C0443199lld:lifeskim
pubmed-article:16288016lifeskim:mentionsumls-concept:C0205179lld:lifeskim
pubmed-article:16288016lifeskim:mentionsumls-concept:C0591833lld:lifeskim
pubmed-article:16288016pubmed:issue22lld:pubmed
pubmed-article:16288016pubmed:dateCreated2005-11-18lld:pubmed
pubmed-article:16288016pubmed:abstractTextWe report a direct comparison of the differential effects of individual p53 mutations on lung tumor growth and progression, and the creation of a murine model of spontaneous advanced lung adenocarcinoma that closely recapitulates several aspects of advanced human pulmonary adenocarcinoma. We generated compound conditional knock-in mice with mutations in K-ras combined with one of three p53 alleles: a contact mutant, a structural mutant, or a null allele. p53 loss strongly promoted the progression of K-ras-induced lung adenocarcinomas, yielding a mouse model that is strikingly reminiscent of advanced human lung adenocarcinoma. The influence of p53 loss on malignant progression was observed as early as 6 weeks after tumor initiation. Furthermore, we found that the contact mutant p53R270H, but not the structural mutant p53R172H, acted in a partially dominant-negative fashion to promote K-ras-initiated lung adenocarcinomas. However, for both mutants, loss-of-heterozygosity occurred uniformly in advanced tumors, highlighting a residual tumor-suppressive function conferred by the remaining wild-type allele of p53. Finally, a subset of mice also developed sinonasal adenocarcinomas. In contrast to the lung tumors, expression of the point-mutant p53 alleles strongly promoted the development of sinonasal adenocarcinomas compared with simple loss-of-function, suggesting a tissue-specific gain-of-function.lld:pubmed
pubmed-article:16288016pubmed:languageenglld:pubmed
pubmed-article:16288016pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16288016pubmed:citationSubsetIMlld:pubmed
pubmed-article:16288016pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16288016pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16288016pubmed:statusMEDLINElld:pubmed
pubmed-article:16288016pubmed:monthNovlld:pubmed
pubmed-article:16288016pubmed:issn0008-5472lld:pubmed
pubmed-article:16288016pubmed:authorpubmed-author:BronsonRoderi...lld:pubmed
pubmed-article:16288016pubmed:authorpubmed-author:JacksTylerTlld:pubmed
pubmed-article:16288016pubmed:authorpubmed-author:TuvesonDavid...lld:pubmed
pubmed-article:16288016pubmed:authorpubmed-author:CrowleyDenise...lld:pubmed
pubmed-article:16288016pubmed:authorpubmed-author:BrownMichaelMlld:pubmed
pubmed-article:16288016pubmed:authorpubmed-author:JacksonErica...lld:pubmed
pubmed-article:16288016pubmed:authorpubmed-author:OliveKenneth...lld:pubmed
pubmed-article:16288016pubmed:issnTypePrintlld:pubmed
pubmed-article:16288016pubmed:day15lld:pubmed
pubmed-article:16288016pubmed:volume65lld:pubmed
pubmed-article:16288016pubmed:ownerNLMlld:pubmed
pubmed-article:16288016pubmed:authorsCompleteYlld:pubmed
pubmed-article:16288016pubmed:pagination10280-8lld:pubmed
pubmed-article:16288016pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:16288016pubmed:meshHeadingpubmed-meshheading:16288016...lld:pubmed
pubmed-article:16288016pubmed:meshHeadingpubmed-meshheading:16288016...lld:pubmed
pubmed-article:16288016pubmed:meshHeadingpubmed-meshheading:16288016...lld:pubmed
pubmed-article:16288016pubmed:meshHeadingpubmed-meshheading:16288016...lld:pubmed
pubmed-article:16288016pubmed:meshHeadingpubmed-meshheading:16288016...lld:pubmed
pubmed-article:16288016pubmed:meshHeadingpubmed-meshheading:16288016...lld:pubmed
pubmed-article:16288016pubmed:meshHeadingpubmed-meshheading:16288016...lld:pubmed
pubmed-article:16288016pubmed:meshHeadingpubmed-meshheading:16288016...lld:pubmed
pubmed-article:16288016pubmed:meshHeadingpubmed-meshheading:16288016...lld:pubmed
pubmed-article:16288016pubmed:meshHeadingpubmed-meshheading:16288016...lld:pubmed
pubmed-article:16288016pubmed:meshHeadingpubmed-meshheading:16288016...lld:pubmed
pubmed-article:16288016pubmed:meshHeadingpubmed-meshheading:16288016...lld:pubmed
pubmed-article:16288016pubmed:meshHeadingpubmed-meshheading:16288016...lld:pubmed
pubmed-article:16288016pubmed:meshHeadingpubmed-meshheading:16288016...lld:pubmed
pubmed-article:16288016pubmed:year2005lld:pubmed
pubmed-article:16288016pubmed:articleTitleThe differential effects of mutant p53 alleles on advanced murine lung cancer.lld:pubmed
pubmed-article:16288016pubmed:affiliationCenter for Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02141, USA.lld:pubmed
pubmed-article:16288016pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16288016pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:16288016pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
entrez-gene:16653entrezgene:pubmedpubmed-article:16288016lld:entrezgene
entrez-gene:22059entrezgene:pubmedpubmed-article:16288016lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16288016lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16288016lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16288016lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16288016lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16288016lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16288016lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16288016lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16288016lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16288016lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16288016lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16288016lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16288016lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16288016lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16288016lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16288016lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16288016lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16288016lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16288016lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16288016lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16288016lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16288016lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16288016lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16288016lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16288016lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16288016lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16288016lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16288016lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16288016lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16288016lld:pubmed